Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 6/2005

01-12-2005 | Letter

Splenic infarction in a pregnant woman with systemic lupus erythematosus

Authors: Mehmet Soy, N. Cenk Sayin, Ercüment Unlü

Published in: Clinical Rheumatology | Issue 6/2005

Login to get access

Abstract

Here we describe a 20-year-old pregnant woman with systemic lupus erythematosus who had high anticardiolipin antibodies and presented with splenic infarction.
Literature
1.
Gladman DD, Urowitz MB (2003) Clinical features. In: Hocherberg M, Silman AJ, Smolen JS, Weinblat ME, Weisman ME (eds) Rheumatology, 3rd edn. Mosby, St Louis, MO, pp 1359–1387
2.
Santilli D, Govoni M, Prandini N, Rizzo N, Trotta F (2003) Autosplenectomy and antiphospholipid antibodies in systemic lupus erythematosus: a pathogenetic relationship? Semin Arthritis Rheum 33:125–133CrossRef
3.
Buskila D, Gladmann DD, Hana W, Kahn HJ (1989) Primary malignant lymphoma of the spleen in systemic lupus erythematosus. J Rheumatol 16:993–996
4.
Arnold MH, Schrieber L (1988) Splenic and renal infarction in systemic lupus erythematosus: association with anti-cardiolipin antibodies. Clin Rheumatol 7:406–410
5.
Enriquez R, Gutierrez A, Sirvent AE, Saez J, Palacios F, Cabezuelo JB (1999) Hepatic hemorrhagic infarction in eclampsia and HELLP syndrome associated with the antiphospholipid syndrome. Gastroenterol Hepatol 22:349–351
6.
McVay CL, Zhang Y, Ko A, Memsic L, Hamburg SI, Morgenstern L et al (2004) Splenic infarction associated with anti-cardiolipin antibody: a report of two cases. Am Surg 70:71–74
7.
Fonner BT, Nemcek AA, Boschman C (1994) CT appearance of splenic infarction in Wegener’s granulomatosis. Am J Radiol 164:353–354
8.
Huong DL, Gatfosse M, Papo T, Barjonet G, Lacombe P, Godeau P (1995) Symptomatic splenic infarction complicating adult Kawasaki disease. Br J Rheumatol 34:579–580
9.
Siva S, Smoleniec J (1999) Splenic infarction in pregnancy. Aust N Z J Obstet Gynaecol 39:252–254
Metadata
Title
Splenic infarction in a pregnant woman with systemic lupus erythematosus
Authors
Mehmet Soy
N. Cenk Sayin
Ercüment Unlü
Publication date
01-12-2005
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 6/2005
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-004-1069-2

Other articles of this Issue 6/2005

Clinical Rheumatology 6/2005 Go to the issue

Original Article

Trapezius muscle imbalance in individuals suffering from frozen shoulder syndrome

Letter

Systemic sclerosis, pulmonary fibrosis and anti-MPO antibodies

Original Article

Arterial occlusion in systemic lupus erythematosus: a good prognostic sign?

Letter

Unusual association of systemic sclerosis and ankylosing spondylitis

Original Article

Low-dose methotrexate treatment for oligoarticular juvenile idiopathic arthritis nonresponsive to intra-articular corticosteroids

Case Report

Immune thrombocytopenic purpura associated with rheumatoid arthritis: case report
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits